Interferon alfa

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alfa
Drug Alias NameInterferon alpha lozengesNatural human lymphobla stoidAlfaferoneOifIFN-alpha +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunomodulatorsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple SclerosisCarcinoma, Renal CellLeukemia, Hairy Cell +[7] 
Global Approved IndicationsMultiple SclerosisCarcinoma, Renal CellLeukemia, Hairy Cell +[7] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryItaly
Original Approved Date1987/01/01
Country/TerritoryItalyJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOtsuka Holdings Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOtsuka Holdings Co Ltd
Inactive CompaniesN/A
Active IndicationsMultiple SclerosisCarcinoma, Renal CellLeukemia, Hairy Cell +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeL03AB
Related LinksKEGG